INTELLIGENT BIO SOLUTIONS IN (INBS) Stock Price, Quote, News and Overview
NASDAQ:INBS - Nasdaq - US36151G6008 - Common Stock - Currency: USD
INBS Quote, Performance and Key Statistics
NASDAQ:INBS (5/1/2025, 3:15:26 PM)
1.31
+0.03 (+2.34%)
The current stock price of INBS is 1.31 USD. In the past month the price decreased by -14.09%. In the past year, price decreased by -50%.
INBS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.41 | 227.20B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.04 | 186.24B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.4 | 153.34B | ||
| SYK | STRYKER CORP | 30.76 | 143.13B | ||
| MDT | MEDTRONIC PLC | 15.66 | 107.28B | ||
| BDX | BECTON DICKINSON AND CO | 12.49 | 49.88B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.09 | 44.46B | ||
| IDXX | IDEXX LABORATORIES INC | 41.66 | 37.98B | ||
| RMD | RESMED INC | 26.16 | 34.89B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.79 | 31.14B | ||
| DXCM | DEXCOM INC | 42.87 | 27.73B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.78 | 23.43B |
Related stock screener links
About INBS
Company Profile
Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. The company is headquartered in New York City, New York and currently employs 13 full-time employees. The company went IPO on 2020-12-23. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Company Info
INTELLIGENT BIO SOLUTIONS IN
135 W 41St St,, Floor 5
New York City NEW YORK US
Employees: 13
Company Website: https://ibs.inc/
Investor Relations: http://investors.ibs.inc/
Phone: 16462336971
INTELLIGENT BIO SOLUTIONS IN / INBS FAQ
What is the stock price of INTELLIGENT BIO SOLUTIONS IN today?
The current stock price of INBS is 1.31 USD. The price increased by 2.34% in the last trading session.
What is the ticker symbol for INTELLIGENT BIO SOLUTIONS IN stock?
The exchange symbol of INTELLIGENT BIO SOLUTIONS IN is INBS and it is listed on the Nasdaq exchange.
On which exchange is INBS stock listed?
INBS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for INTELLIGENT BIO SOLUTIONS IN stock?
7 analysts have analysed INBS and the average price target is 12.24 USD. This implies a price increase of 834.35% is expected in the next year compared to the current price of 1.31. Check the INTELLIGENT BIO SOLUTIONS IN stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INTELLIGENT BIO SOLUTIONS IN worth?
INTELLIGENT BIO SOLUTIONS IN (INBS) has a market capitalization of 8.88M USD. This makes INBS a Nano Cap stock.
How many employees does INTELLIGENT BIO SOLUTIONS IN have?
INTELLIGENT BIO SOLUTIONS IN (INBS) currently has 13 employees.
What are the support and resistance levels for INTELLIGENT BIO SOLUTIONS IN (INBS) stock?
INTELLIGENT BIO SOLUTIONS IN (INBS) has a support level at 1.27 and a resistance level at 1.3. Check the full technical report for a detailed analysis of INBS support and resistance levels.
Is INTELLIGENT BIO SOLUTIONS IN (INBS) expected to grow?
The Revenue of INTELLIGENT BIO SOLUTIONS IN (INBS) is expected to grow by 177.96% in the next year. Check the estimates tab for more information on the INBS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INTELLIGENT BIO SOLUTIONS IN (INBS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of INBS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of INBS, evaluating the profitability, health, valuation and growth aspects
- INTELLIGENT BIO SOLUTIONS IN (INBS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INTELLIGENT BIO SOLUTIONS IN (INBS) Sales and EPS estimates to see what analysts future expectations are.
- INTELLIGENT BIO SOLUTIONS IN (INBS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INTELLIGENT BIO SOLUTIONS IN (INBS) Insider and Institutional Ownership to learn about the owners and their transactions.
- INTELLIGENT BIO SOLUTIONS IN (INBS) Stock Chart to make your own analysis
- INTELLIGENT BIO SOLUTIONS IN (INBS) Latest news and press-releases to stay up to date.
Does INTELLIGENT BIO SOLUTIONS IN (INBS) stock pay dividends?
INBS does not pay a dividend.
What is the Price/Earnings (PE) ratio of INTELLIGENT BIO SOLUTIONS IN (INBS)?
INTELLIGENT BIO SOLUTIONS IN (INBS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.55).
What is the Short Interest ratio of INTELLIGENT BIO SOLUTIONS IN (INBS) stock?
The outstanding short interest for INTELLIGENT BIO SOLUTIONS IN (INBS) is 8.1% of its float. Check the ownership tab for more information on the INBS short interest.
INBS Technical Analysis
INBS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to INBS. The financial health of INBS is average, but there are quite some concerns on its profitability.
INBS Financial Highlights
Over the last trailing twelve months INBS reported a non-GAAP Earnings per Share(EPS) of -3.55. The EPS increased by 97.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -123.18% | ||
| ROE | -245.01% | ||
| Debt/Equity | 0 |
INBS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to INBS. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 65.94% and a revenue growth 177.96% for INBS